Literature DB >> 6186076

Monoclonal antibody analysis of serotype-restricted and unrestricted bluetongue viral antigenic determinants.

J A Appleton, G J Letchworth.   

Abstract

Twenty-one monoclonal antibodies that react with bluetongue virus (BTV) and have restricted or unrestricted serotype specificities were identified in culture supernatants of hybridomas derived from lymphocytes of mice immunized with BTV serotype 17. Hybridomas were screened and antibody specificities characterized in a solid-phase radioimmunoassay and by immunoprecipitation with radiolabeled, BTV 17-infected cell lysates. Three general serotype specificities were demonstrated by 13 antibodies that precipitated structural viral protein 9 (VP 9). One antibody precipitated VP 7, a 48,000 dalton nonstructural protein, and reacted in radioimmunoassay with 20 BTV serotypes and Epizootic Hemorrhagic Disease of Deer Virus serotype 1 (EHDV 1), EHDV 2, and Ibaraki virus, but not with uninfected cells. One serotype-specific antibody neutralized infectivity, inhibited hemagglutination by BTV 17, and precipitated VP 2 and VP 3. A second antibody, with restricted serotype specificity, precipitated VP 2 and VP 8. These results confirm those of others (Huismans and Erasmus, Onderstepoort J. Vet. Res. 48, 51-58, 1981) that BTV serotype-specific and neutralizing epitopes are associated with VP 2.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6186076     DOI: 10.1016/0042-6822(83)90345-8

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  Differential serologic responses to reassortant bluetongue viruses recovered from a bull.

Authors:  M S Maia; B I Osburn
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

Review 2.  The biochemistry of orbiviruses. Brief review.

Authors:  R P Spence; N F Moore; P A Nuttall
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

3.  Characterization of African swine fever virus antigenic proteins by immunoprecipitation.

Authors:  G J Letchworth; T C Whyard
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

4.  Recombinant virus vaccine for bluetongue disease in sheep.

Authors:  P Roy; T Urakawa; A A Van Dijk; B J Erasmus
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

5.  Vaccinia virus expression of the VP7 protein of South African bluetongue virus serotype 4 and its use as an antigen in a capture ELISA.

Authors:  M Cloete; D H du Plessis; A A van Dijk; H Huismans; G J Viljoen
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

6.  Identification of a neutralizing epitope shared by bluetongue virus serotypes 2 and 13.

Authors:  S Ristow; L Leendersten; J Gorham; T Yilma
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

7.  Anti-idiotypic antibody as potential serodiagnostic reagent for detection of bluetongue virus infection.

Authors:  E M Zhou; W Huang
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

Review 8.  The application of monoclonal antibodies in the study of viruses.

Authors:  M J Carter; V ter Meulen
Journal:  Adv Virus Res       Date:  1984       Impact factor: 9.937

9.  Serological Cross-Reactions between Expressed VP2 Proteins from Different Bluetongue Virus Serotypes.

Authors:  Petra C Fay; Fauziah Mohd Jaafar; Carrie Batten; Houssam Attoui; Keith Saunders; George P Lomonossoff; Elizabeth Reid; Daniel Horton; Sushila Maan; David Haig; Janet M Daly; Peter P C Mertens
Journal:  Viruses       Date:  2021-07-26       Impact factor: 5.048

10.  Heterogeneity of the L2 gene of field isolates of bluetongue virus serotype 17 from the San Joaquin Valley of California.

Authors:  C A de Mattos; C C de Mattos; B I Osburn; N J MacLachlan
Journal:  Virus Res       Date:  1994-01       Impact factor: 3.303

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.